Thorac Cardiovasc Surg 2006; 54(6): 373-380
DOI: 10.1055/s-2006-924194
Editorial

© Georg Thieme Verlag KG Stuttgart · New York

Lymphatic Spread in Resectable Lung Cancer: Can We Trust in a Sentinel Lymph Node?

J. Schirren1 , T. Bergmann1 , S. Beqiri1 , S. Bölükbas1 , A. Fisseler-Eckhoff1 , I. Vogt-Moykopf2
  • 1Department of Thoracic Surgery, HSK-Wiesbaden, Wiesbaden, Germany
  • 2Former Head of Department of Thoracic Surgery, Thoraxklinik, Heidelberg-Rohrbach, Germany
Further Information

Publication History

Received December 19, 2005

Publication Date:
07 September 2006 (online)

Abstract

The aim of this study was to describe lymphatic spread in resected lung cancer patients and evaluate for the presence for a reliable sentinel lymph node. Onethousand and eighty-eight patients with NSCLC underwent resection. Twelve to sixteen percent of the patients with primaries in the upper lobes had an involvement in the upper mediastinum; in 12 %, it was subcarinal, in 6 % and 3 %, in the lower mediastinum at paraoesophageal and ligamentum pulmonale sites, respectively. The rate of “lymph node skipping” is between 31 and 74 %. An isolated involvement of mediastinal nodes is possible without involvement of the N-1 position. Irrespective of the location of the primary tumour, there is a high incidence of “lymph node skipping” because of the specific architecture of the pulmonary, hilar and medistinal lymph nodes. Therefore, a reliable sentinel lymph node in lung cancer cannot be defined. In conclusion, systematic lymph node dissection in anatomical compartments is the gold standard for evaluation of the exact pN stage. Furthermore, a complete R/O-resection is a prognostically relevant factor in the surgery of NSCLC.

References

  • 1 Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastases in resected lung cancer.  J Thorac Cardiovasc Surg. 1978;  76 832-839
  • 2 Riepert T, Müller K M. Tumorausbreitung in Lungen mit Silikosen.  Verh Deutsch Ges Pathol. 1984;  68 407-409
  • 3 Kubik S. Anatomie der Lymphgefäße der Lunge. Eckert P Intensivmedizin Anaesthesiologie. Vol. 2: Volumenregulation und Flüssigkeitslunge. Stuttgart; Thieme Verlag 1976: 10-16
  • 4 Hata E, Troidl H, Haegawas T. In-vivo-Untersuchung der Lymphoszintigraphie: Eine neue diagnostische Technik. Hamelmann H, Troidl H Behandlung des Bronchialkarzinoms. Stuttgart; Thieme Verlag 1981: 27
  • 5 Hoffmann E. Die Abflußwege der Lymphe und ihre Bedeutung für die Ausbreitung maligner Tumoren.  Bruns Beitr Klin Chir. 1959;  199 451-457
  • 6 Knoche E, Ring H. Die Mediastinoskopie. Stuttgart; Schattauer 1964
  • 7 Riquet M, Hidden G, Debesse B. Direct lymphatic drainage of lung segments to the mediastinal nodes. An anatomic study on 260 adults.  J Thorac Cardiovasc Surg. 1989;  97 623-632
  • 8 Murakami G, Taniguchi I. Histological heterogeneity and intra nodal shunt flow in lymph nodes from elderly subjects: a cadaveric study.  Ann Surg Oncol. 2004;  11 279-284
  • 9 Borrie J. Lung Cancer: Surgery and Survival. New York; Appleton-Centry-Crofts 1965
  • 10 Martini F, Flehinger B J. The role of surgery in N2 lung cancer.  Surg Clin North Am. 1987;  67 1037-1045
  • 11 UICC and AJCC TNM-Supplement. Heidelberg, New York; Springer 1997
  • 12 Kiyono K, Sone S, Sakai F, Imai Y. et al . The number and size of normal mediastinal lymph nodes: a post mortem study.  AJR. 1988;  150 771-776
  • 13 Little A G, Delloyos A, Kirgan D M, Arcomano T R, Murray K D. Intraoperative lymphatic mapping for non-small cell cancer: the sentinel node technique.  J Thorac Cardiovasc Surg. 1999;  117 220-234
  • 14 Greschuchna G, Maassen W. Die lymphogenen Absiedlungswege des Bronchialkarzinoms. Stuttgart; Thieme Verlag 1973: 25-52
  • 15 Libsitz H I, McKenna R J, Montain C F. Patterns of mediastinal metastases in bronchogenic carcinoma.  Chest. 1986;  90 229-235
  • 16 Mozzilo N, Chiesa F, Botti G. et al . Sentinel node biopsy in head and neck cancer.  Ann Surg Oncol. 2001;  135 926-932
  • 17 Schmidt F E, Woltering E A, Webb W R, Garcia O M, Cohen J E, Rozans M H. Sentinel nodal assessment in patients with carcinoma of the lung.  Ann Thorac Surg. 2002;  74 870-875
  • 18 Tsioulias G J, Wood T F, Morton D L. et al . Lymphatic mapping and focused analysis of sentinel lymph nodes upstage gastrointestinal neoplasm.  Arch Surg. 2000;  135 926-932
  • 19 Schirren J. Die systematische mediastinale Lymphknotendissektion beim Bronchialkarzinom. Indikation, Technik, Ergebnisse. Habilitationsschrift Medizinische Gesamtfakultät der Ruprecht-Karls-Universität zu Heidelberg. 1995
  • 20 Schirren J, Richter W, Schneider P, Vogt-Moykopf I. Grundlagen und Ergebnisse der systematischen Lymphknotendissektion beim operierten Bronchialkarzinom.  Chirurg. 1996;  67 869-876
  • 21 Junker K, Müller K M. Metastasierung beim Bronchialkarzinom.  Z Herz Thorax Gefäßchir. 1989;  3 189-194
  • 22 Schirren J, Schneider P, Richter W, Trainer C, Muley T, Bülzebruck H, Vogt-Moykopf I. Radikalität und Lymphknotendissektion beim Lungenkarzinom.  Langenbecks Arch Chir. 1996;  (Suppl 2) 790-797
  • 23 Morton D L, Wen D, Wong J. et al . Technical details of intraoperative lymphatic mapping for early stage melanoma.  Arch Surg. 1992;  127 392-399
  • 24 Aiku T, Higashi H, Natsugoe S. et al . Can sentinel node navigation surgery reduce the extent of lymph node dissection in gastric cancer?.  Ann Surg Oncol. 2001;  8 90-93
  • 25 Liptay M D, Masters G A, Winchester D J, Edelman B L, Garrido B J, Hirschtritt T R, Perlman R M, Fry W A. Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer.  Ann Thoracic Surg. 2000;  70 384-389

MD, PhD, FECTS Joachim Schirren

Department of Thoracic Surgery
HSK-Wiesbaden

Ludwig-Erhard-Straße 100

65199 Wiesbaden

Germany

Phone: + 49 6 11 43 31 32

Fax: + 49 6 11 43 31 32

Email: joachim.schirren@hsk-wiesbaden.de

    >